Clinical Trial Update: Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 3-weekly versus 5-weekly S-1 plus cisplatin in advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Asan Medical Center | Conditions: Advanced Gastric Cancer | Phase 3 | Status: COMPLETED